Literature DB >> 28078127

Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer.

Antonio Macrì1, Edoardo Saladino2.   

Abstract

Entities:  

Year:  2016        PMID： 28078127      PMCID： PMC5177590          DOI： 10.21037/jgo.2016.08.10

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  10 in total

Review 1.  Locoregional treatment of peritoneal carcinomatosis from gastric cancer.

Authors:  F Bozzetti; W Yu; Dario Baratti; Shigeki Kusamura; Marcello Deraco
Journal:  J Surg Oncol       Date:  2008-09-15       Impact factor: 3.454

2.  Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.

Authors:  B Sadeghi; C Arvieux; O Glehen; A C Beaujard; M Rivoire; J Baulieux; E Fontaumard; A Brachet; J L Caillot; J L Faure; J Porcheron; J L Peix; Y François; J Vignal; F N Gilly
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

3.  Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.

Authors:  Emel Canbay; Akiyoshi Mizumoto; Masumi Ichinose; Haruaki Ishibashi; Shouzou Sako; Masamitsu Hirano; Nobuyuki Takao; Yutaka Yonemura
Journal:  Ann Surg Oncol       Date:  2013-12-20       Impact factor: 5.344

Review 4.  Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future.

Authors:  Ahmed Dehal; J Joshua Smith; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2016-02

Review 5.  A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

Authors:  Tristan D Yan; Deborah Black; Paul H Sugarbaker; Jacqui Zhu; Yutaka Yonemura; George Petrou; David L Morris
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

6.  The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.

Authors:  Edoardo Saladino; Francesco Fleres; Carmelo Mazzeo; Vincenzo Pruiti; Michela Scollica; Maurizio Rossitto; Eugenio Cucinotta; Antonio Macrì
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

Review 7.  Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Authors:  Paul H Sugarbaker; Wansik Yu; Yutaka Yonemura
Journal:  Semin Surg Oncol       Date:  2003

8.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

9.  Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.

Authors:  Florian Seyfried; Burkhard H von Rahden; Alexander D Miras; Martin Gasser; Uwe Maeder; Volker Kunzmann; Christoph-Thomas Germer; Jörg Pelz; Alexander G Kerscher
Journal:  BMC Cancer       Date:  2015-02-19       Impact factor: 4.430

10.  Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials.

Authors:  Jingxu Sun; Yongxi Song; Zhenning Wang; Peng Gao; Xiaowan Chen; Yingying Xu; Jiwang Liang; Huimian Xu
Journal:  BMC Cancer       Date:  2012-11-16       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.